We show you our most important and recent visitors news details Moderna says its COVID-19 vaccine is 'highly effective' in children aged 12-17 in the following article
Hind Al Soulia - Riyadh - WASHINGTON — Moderna said its mRNA COVID-19 vaccine, which is already approved for adults in the EU, is highly effective in children over 12 years old.
The results of a trial of 3,700 12- to 17-year-olds in the US could pave the way towards the vaccine being made available to younger age groups.
After two doses of the COVID-19 vaccine, there were no cases of the virus in study participants, Moderna said in a press release on Tuesday, meaning it was 100% effective at preventing COVID-19.
The vaccine was 93 percent effective in children ages 12-17 two weeks after a single dose, the company added.
“We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,” said Stéphane Bancel, Chief Executive Officer of Moderna, in a statement.
“We will submit these results to the US FDA and regulators globally in early June and request authorization. We remain committed to doing our part to help end the COVID-19 pandemic.”
These were the details of the news Moderna says its COVID-19 vaccine is 'highly effective' in children aged 12-17 for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.